Summary & Overview
HCPCS Q4198: Genesis Amniotic Membrane, Per Square Centimeter
HCPCS Level II code Q4198 covers the Genesis amniotic membrane product billed per square centimeter as an add-on supply in addition to a primary procedure. As an add-on HCPCS code for biologic graft material, it is relevant for surgical specialties and wound-care services where amniotic membrane is used to promote healing and tissue regeneration. Nationally, the code matters because it affects billing for advanced biologic wound therapies and impacts facility and professional reimbursement pathways when used alongside primary surgical procedure codes.
Key payers considered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context for use of the product, payer coverage patterns and common modifiers encountered, and benchmarking guidance for how the add-on nature of the code interacts with primary procedure billing. The publication also outlines coding practice considerations, documentation elements commonly required by payers, and how Q4198 integrates into service lines that perform surgical or procedural wound care.
This summary offers a national perspective on coding and billing for this biologic graft product, providing clinicians, coders, and revenue-cycle staff with the essential information needed to identify when Q4198 applies and what topics to address when preparing claims involving amniotic membrane adjuncts.
Billing Code Overview
HCPCS Level II code Q4198 describes Genesis amniotic membrane, billed per square centimeter as an add-on supply that is listed separately in addition to a primary procedure. This code represents a biologic graft product derived from human amniotic membrane designed for application in surgical and wound-care procedures.
Service type: Biologic graft / surgical wound adjunct
Typical site of service: Operating room or outpatient surgical setting, wound care clinic, or other procedural care locations where a primary surgical or wound procedure is performed
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 68-year-old diabetic patient with a chronic, non-healing full-thickness lower extremity ulcer presents to a wound care clinic after conservative measures (dressings, offloading, local debridement) failed over several weeks. The wound demonstrates exposed tendon and poor matrix regeneration. The wound care team — typically a podiatrist, plastic surgeon, or wound care specialist — performs sharp surgical debridement in a procedure room or ambulatory surgery center. After achieving a clean wound bed and hemostasis, the clinician applies a cryopreserved or processed amniotic membrane product (Genesis amniotic membrane) trimmed to size and measured in square centimeters. The product is used as an adjunct to promote epithelialization and modulate inflammation. The clinician records the exact square centimeters of product used and adds the add-on HCPCS Level II code Q4198 to the claim, reported in addition to the primary wound procedure or debridement CPT code. Typical sites of service include outpatient wound care clinics, physician offices with procedure rooms, ambulatory surgery centers, and inpatient operating rooms when used during a surgical reconstruction. Common clinical workflow steps: initial evaluation and wound measurement, informed consent, surgical or sharp debridement (if applicable), measurement and application of the amniotic membrane product, dressing and offloading, and documentation of product lot/size, number of square centimeters used, and indication for use.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 |